Search results
Results from the WOW.Com Content Network
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers (Max Hodak, Benjamin Rapoport, Dongjin Seo, Paul Merolla, Philip Sabes, Tim Gardner, Tim Hanson, and Vanessa Tolosa).
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
To help run Neuralink Musk called in the help of Shivon Zilis, who previously worked at Tesla, and was a director at OpenAI, which he co founded but no longer owns. Musk and Zilis are close, so ...
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...
Neuralink was formed in 2016, in the hope of creating a new way for humans to interface with machines. Mr Musk has suggested it could offer a way for people to integrate virtual reality with their ...
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. [1] The vaccine delivers molecules of antigen -encoding mRNA into cells , which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus ) or by a ...
According to Elon Musk, the first human received an implant from his computer-brain interface company Neuralink over the weekend. In a Monday post on X, the platform formerly known as Twitter ...
Although the quality and quantity of antibody production by a potential vaccine is intended to neutralize the COVID‑19 infection, a vaccine may have an unintended opposite effect by causing antibody-dependent disease enhancement (ADE), which increases the virus attachment to its target cells and might trigger a cytokine storm if a vaccinated ...